3

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: July 17, 2008
Period of Report: January 31, 2008
Accession Number: 0001209191-08-042854

View Document ↗ View on SEC.gov ↗